These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36513376)

  • 1. Vir2Drug: a drug repurposing framework based on protein similarities between pathogens.
    Minadakis G; Tomazou M; Dietis N; Spyrou GM
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36513376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PathExNET: A tool for extracting pathway expression networks from gene expression statistics.
    Minadakis G; Muñoz-Pomer Fuentes A; Tsouloupas G; Papatheodorou I; Spyrou GM
    Comput Struct Biotechnol J; 2021; 19():4336-4344. PubMed ID: 34429851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing.
    Martinez-Hernandez JE; Hammoud Z; de Sousa AM; Kramer F; Monte-Neto RLD; Maracaja-Coutinho V; Martin AJM
    Microbiol Spectr; 2021 Oct; 9(2):e0101821. PubMed ID: 34668739
    [No Abstract]   [Full Text] [Related]  

  • 4. Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.
    Chartier M; Morency LP; Zylber MI; Najmanovich RJ
    BMC Pharmacol Toxicol; 2017 Apr; 18(1):18. PubMed ID: 28449705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Web Tool for Ranking Candidate Drugs Against a Selected Disease Based on a Combination of Functional and Structural Criteria.
    Karatzas E; Minadakis G; Kolios G; Delis A; Spyrou GM
    Comput Struct Biotechnol J; 2019; 17():939-945. PubMed ID: 31360332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.
    Schor S; Einav S
    ACS Infect Dis; 2018 Feb; 4(2):88-92. PubMed ID: 29298032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using molecular-mimicry-inducing pathways of pathogens as novel drug targets.
    Garg A; Kumari B; Singhal N; Kumar M
    Drug Discov Today; 2019 Sep; 24(9):1943-1952. PubMed ID: 30366058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing: a better approach for infectious disease drug discovery?
    Law GL; Tisoncik-Go J; Korth MJ; Katze MG
    Curr Opin Immunol; 2013 Oct; 25(5):588-92. PubMed ID: 24011665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing of FDA approved drugs and their validation against potential drug targets for
    Kesharwani A; Chaurasia DK; Katara P
    J Biomol Struct Dyn; 2022 Sep; 40(14):6255-6271. PubMed ID: 33525976
    [No Abstract]   [Full Text] [Related]  

  • 12. A network-based drug repurposing method via non-negative matrix factorization.
    Sadeghi S; Lu J; Ngom A
    Bioinformatics; 2022 Feb; 38(5):1369-1377. PubMed ID: 34875000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network analytics for drug repurposing in COVID-19.
    Siminea N; Popescu V; Sanchez Martin JA; Florea D; Gavril G; Gheorghe AM; Iţcuş C; Kanhaiya K; Pacioglu O; Popa LL; Trandafir R; Tusa MI; Sidoroff M; Păun M; Czeizler E; Păun A; Petre I
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repositioning
    Kori M; Turanli B; Arga KY
    Front Oncol; 2023; 13():1096081. PubMed ID: 36761959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the repurposing of drugs/molecules for the management of COVID-19.
    Sharma D; Kunamneni A
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):889-897. PubMed ID: 33270490
    [No Abstract]   [Full Text] [Related]  

  • 16. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Drugs Based on Evolutionary Relationships Between Targets of Approved Drugs and Proteins of Interest.
    Chakraborti S; Ramakrishnan G; Srinivasan N
    Methods Mol Biol; 2019; 1903():45-59. PubMed ID: 30547435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug-drug links based on graph neural network.
    Cui C; Ding X; Wang D; Chen L; Xiao F; Xu T; Zheng M; Luo X; Jiang H; Chen K
    Bioinformatics; 2021 Sep; 37(18):2930-2937. PubMed ID: 33739367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network-based Drug Repurposing: A Critical Review.
    Selvaraj N; Swaroop AK; Nidamanuri BSS; Kumar RR; Natarajan J; Selvaraj J
    Curr Drug Res Rev; 2022; 14(2):116-131. PubMed ID: 35156575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.